Phase 3 Dialysis Clinical Trials
14 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–14 of 14 trials
Recruiting
Phase 3
meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
Peritoneal Dialysis Complication
University Health Network, Toronto20 enrolled1 locationNCT05715814
Recruiting
Phase 3
A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders
Hyperphosphatemia Patients on Hemodialysis
Taisho Pharmaceutical Co., Ltd.100 enrolled1 locationNCT07285291
Recruiting
Phase 3
Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study
Peritoneal DialysisAnaemia
Hull University Teaching Hospitals NHS Trust30 enrolled1 locationNCT06884280
Recruiting
Phase 3
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
HyperphosphatemiaDialysisChronic Kidney Disease, Receiving Dialysis+1 more
Alebund Pharmaceuticals264 enrolled42 locationsNCT06933472
Recruiting
Phase 3
Therapeutic Effect of Manuka Honey Oral Rinse in Periodontitis Patients Undergoing Hemodialysis
HemodialysisPeriodontitis
Ain Shams University150 enrolled1 locationNCT06726876
Recruiting
Phase 3
A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
Hyperphosphatemia Patients on Hemodialysis
Taisho Pharmaceutical Co., Ltd.300 enrolled1 locationNCT07285304
Not Yet Recruiting
Phase 3
Colchicine for coronary protection on dialysis (CCPD)
Chronic Kidney DiseaseCardiovascular DiseaseHaemodialysis
Sydney Local Health District20 enrolled1 locationACTRN12625001063404
Recruiting
Phase 3
Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
Chronic Kidney DiseaseAnemiaChronic Kidney Disease 5D+1 more
Biocad228 enrolled2 locationsNCT07119372
Recruiting
Phase 3
Randomised Clinical Trial Comparing Drug-coated Balloon to Plain Balloon for All Peripheral AVF Stenosis
Arteriovenous FistulaArteriovenous Fistula StenosisDialysis Access Malfunction
Singapore General Hospital94 enrolled1 locationNCT06553443
Recruiting
Phase 3
Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients
Tunnelled Hemodialysis Catheter Infection
University Hospital, Clermont-Ferrand400 enrolled1 locationNCT03083184
Recruiting
Phase 3
The effect of lower salt exposure on the cardiac structure and function of patients on home haemodialysis
Cardiovascular outcomes in dialysis patients
The Centre for Clinical Research and effective practice (CCRep), registered with the New Zealand Charities Commission (ref# CC21537)118 enrolled1 locationACTRN12611000975998
Suspended
Phase 3Phase 4
A Randomized controlled trial comparing Topical use of Mupirocin versus Medihoney for the prevention of infection at Tenckhoff Exit Site in Peritoneal Dialysis Patients
Peritineal Dialysis patients
Department of Renal Medicine380 enrolled1 locationACTRN12611000297921
Completed
Phase 3
The Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study
end-stage kidney disease
haemodialysis
peritoneal dialysis
Australasian Kidney Trials Network- University of Queensland150 enrolled10 locationsACTRN12609000174280
Completed
Phase 3Phase 4
A placebo-controlled trial to assess the effect of aspirin and fish oil (omega-3 fatty acids) in the prevention of early thrombosis in arterio-venous fistulae in patients with chronic kidney disease requiring haemodialysis
Early thrombosis in arterio-venous fistulae in patients with Stage IV or V chronic kidney disease requiring haemodialysis
Australasian Kidney Trials Network950 enrolled26 locationsACTRN12607000569404